Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert

Stock Information for InMed Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About InMed Pharmaceuticals Inc.

Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx(TM) PCR Pro® with Mexico Distributor Agreement
Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx(TM) PCR Point-of-Care Platform Capabilities
Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara
Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Co-Diagnostics Reports First Quarter 2026 Financial Results
Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial City
Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and Webcast
Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.